Strategy for Identifying Rational Sensitivity Analysis Using PBPK Modeling for Precipitant Drug-Drug Interaction Predictions.
Saved in:
| Title: | Strategy for Identifying Rational Sensitivity Analysis Using PBPK Modeling for Precipitant Drug-Drug Interaction Predictions. |
|---|---|
| Authors: | Taskar KS; Drug Metabolism and Pharmacokinetics, Research Technologies, GSK, Stevenage, UK., Sharma P; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, UK., Rowland Yeo K; Certara UK Limited, Certara Predictive Technologies Division, Sheffield, UK. |
| Source: | Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2026 Feb; Vol. 119 (2), pp. 314-317. Date of Electronic Publication: 2025 Nov 13. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41231089 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Strategy for Identifying Rational Sensitivity Analysis Using PBPK Modeling for Precipitant Drug-Drug Interaction Predictions. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Taskar+KS%22">Taskar KS</searchLink>; Drug Metabolism and Pharmacokinetics, Research Technologies, GSK, Stevenage, UK.<br /><searchLink fieldCode="AU" term="%22Sharma+P%22">Sharma P</searchLink>; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Rowland+Yeo+K%22">Rowland Yeo K</searchLink>; Certara UK Limited, Certara Predictive Technologies Division, Sheffield, UK. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220372741%22">Clinical pharmacology and therapeutics</searchLink> [Clin Pharmacol Ther] 2026 Feb; Vol. 119 (2), pp. 314-317. <i>Date of Electronic Publication: </i>2025 Nov 13. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0372741 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-6535 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200099236%22">00099236 </searchLink><i>NLM ISO Abbreviation: </i>Clin Pharmacol Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41231089 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/cpt.70127 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 314 Titles: – TitleFull: Strategy for Identifying Rational Sensitivity Analysis Using PBPK Modeling for Precipitant Drug-Drug Interaction Predictions. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Taskar KS – PersonEntity: Name: NameFull: Sharma P – PersonEntity: Name: NameFull: Rowland Yeo K IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2026 Feb Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1532-6535 Numbering: – Type: volume Value: 119 – Type: issue Value: 2 Titles: – TitleFull: Clinical pharmacology and therapeutics Type: main |
| ResultId | 1 |
